Business Standard

Indian pharma see no threat from Donald Trump's policies

In his press conference, Trump targeted drug makers and vowed to bring back production in the US

Donald Trump, us president
Premium

Donald Trump speaks to the press during an announcement in New York. Photo: Reuters

Aneesh Phadnis Mumbai
The proposed changes in the US healthcare policies will have minimal impact on Indian companies, drug makers and sector experts said on Thursday.

On Wednesday, US president-elect Donald Trump announced he will repeal and replace Obamacare Act, bring back pharma jobs to the US and introduce a new bidding procedure for Medicare, the government-backed social insurance programme.

Pharma companies stocks fell 1-3% during the opening trade on the BSE on Thursday but recouped the losses and sector experts blamed the drop in price to an overreaction.

"The Indian pharma industry has contributed significantly to contain and bring down healthcare costs

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in